REPEATED INHALATION OF NEBULIZED ALBUTEROL DID NOT INDUCE ARRHYTHMIASIN A PATIENT WITH WOLFF-PARKINSON-WHITE SYNDROME AND ASTHMA

Authors
BONNIN AJ RICHMOND GW MUSTO PK VOLGMAN AS MOY JN
Citation
Aj. Bonnin et al., REPEATED INHALATION OF NEBULIZED ALBUTEROL DID NOT INDUCE ARRHYTHMIASIN A PATIENT WITH WOLFF-PARKINSON-WHITE SYNDROME AND ASTHMA, Chest, 103(6), 1993, pp. 1892-1894
Citations number
6
Categorie Soggetti
Respiratory System
Journal title
Chest → ACNP
ISSN journal
00123692
Volume
103
Issue
6
Year of publication
1993
Pages
1892 - 1894
Database
ISI
SICI code
0012-3692(1993)103:6<1892:RIONAD>2.0.ZU;2-4
Abstract
It has been assumed that in asthmatic patients with Wolff-Parkinson-Wh ite (WPW) syndrome, ablative therapy for the condition is necessary fo r the safe treatment of the asthma with beta2-adrenergic drugs. The fo llowing case report illustrates that inhaled albuterol was safely admi nistered to an asthmatic patient with electrocardiographic evidence of preexcitation, without the need of an ablative procedure. This case r eport is, to our knowledge, the first in the literature in which the c ardiac rhythm of a patient with WPW syndrome was monitored during repe ated inhalations of a beta2-agonist.